Breakthrough T1D Celebrates Ford's Generosity with Auction Proceeds for Diabetes Research

Recognition of Generosity by Ford

Breakthrough T1D, the preeminent organization advocating for Type 1 Diabetes (T1D) research, recently expressed its heartfelt thanks to Ford Motor Company for their remarkable support. This expression of gratitude follows the auction of the first Ford Mustang Dark Horse SC at the Barrett-Jackson Scottsdale event, which fetched an impressive $1.25 million. The entire proceeds from this auction have been earmarked to bolster research aimed at advancing T1D treatment and management.

In remarks highlighting the partnership, Dr. Aaron J. Kowalski, CEO of Breakthrough T1D, noted, "The generous donation from Ford aligns with our quest to improve the lives of those afflicted by T1D. Their support has been instrumental, inspiring various stakeholders to join in our pursuit of breakthroughs that can transform T1D care and possibly pave the way toward a cure."

The auction, featuring nine charity cars, created waves of excitement among automotive enthusiasts while also serving a noble cause. Ford, a long-time ally of Breakthrough T1D, has raised over $85 million for T1D research through various platforms since 1998, underlining its unwavering commitment to this crucial cause.

Importance of Ford’s Contribution

The impact of Ford's donation extends beyond monetary support. Funds generated will build a foundation for vital research focusing on disease-modifying therapies, innovative management technology for daily T1D needs, treatments for related complications, and pioneering cell therapies that have the potential to cure the disease altogether.

Ford's partnership is pivotal to the objectives of Breakthrough T1D, which aims to not only discover a cure but enhance day-to-day life for individuals living with T1D. As part of their commitment, they continue to assist in numerous fundraising endeavors that further the research goal and foster the T1D community's growth.

Understanding Type 1 Diabetes (T1D)

Type 1 Diabetes, an autoimmune disorder, leads to the pancreas producing little to no insulin. As a result, those affected must rely on insulin therapy to manage their condition, which presents risks of both short-term and long-term complications. These complications can range from fluctuating blood sugar levels to serious issues such as kidney, eye, nerve, and heart damage.

Globally, T1D affects around 9.5 million individuals. Contrary to popular belief, the disorder can develop at any age, with nearly 50% of diagnoses occurring in adults. The exact etiology of T1D remains unclear, but both genetics and environmental triggers are believed to play significant roles. Currently, no definitive cure for T1D exists, making research and funding critical in this area.

Conclusion

In conclusion, the collaboration between Breakthrough T1D and Ford signifies a monumental leap forward in the fight against Type 1 Diabetes. The funds raised from the auction will lay the groundwork for research and innovative solutions that can drastically improve the lives of individuals managing this condition. Together with Ford, Breakthrough T1D moves closer to realizing its vision of a future where T1D is no longer a burden, but a manageable condition, paving the way for new eras of treatment and hope for millions worldwide.